SZSE Releases
Companies
Releases
Pricing
Home
/
Companies
/
Zhejiang Jolly Pharmaceutical Co., Ltd.
/
Release
300181
SZSE
Announcement on the response to the inquiry letter regarding the review of the issuance of convertible corporate bonds to unspecified objects and the update of application documents such as the fundraising prospectus
Zhejiang Jolly Pharmaceutical Co., Ltd.
·
May 20, 2026
Full Translation